{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:54:04Z","timestamp":1782658444042,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["NICHD"],"award-info":[{"award-number":["NICHD"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD108041"],"award-info":[{"award-number":["R01HD108041"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD100201"],"award-info":[{"award-number":["R01HD100201"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["R01NR019220"],"award-info":[{"award-number":["R01NR019220"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R00MH121166"],"award-info":[{"award-number":["R00MH121166"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K01MH122326"],"award-info":[{"award-number":["K01MH122326"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In Kenya, 65% of sexually active unmarried women use modern contraceptives, a population at increased risk of HIV acquisition compared to other populations. Anchoring HIV prevention services, including pre-exposure prophylaxis (PrEP), to trusted contraceptive delivery settings offers opportunities to efficiently reach this important population. In Kenya, almost half (40%) of women accessing contraception services do so outside traditional healthcare facilities, such as retail pharmacies. Thus, integrating PrEP services into retail pharmacies may increase options for reaching adolescent girls and young women (AGYW) who could benefit from PrEP. Efforts are underway to define care pathways for pharmacy-delivered PrEP services in Kenya, including unsupported and supported models with nurse navigators.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The AGYW Pharmacy PrEP study is an unblinded 2-arm cluster-randomized controlled trial in Kisumu, Kenya. The objective is to determine the effect that unsupported versus supported pharmacy-delivered PrEP services has on PrEP initiation, persistence, and adherence among AGYW seeking contraception. Twenty retail pharmacies offering pharmacy provider-led PrEP delivery will be randomized 1:1 to either receive or not receive a nurse navigator to support PrEP delivery. Eligible AGYW (<jats:italic>n<\/jats:italic>\u2009=\u20091900 total, <jats:italic>n<\/jats:italic>\u2009=\u2009950\/arm) will be\u2009\u2265\u200915\u00a0years old, purchasing a method of contraception at the pharmacy. Trained pharmacy provider will offer eligible AGYW either daily oral PrEP or the monthly DPV vaginal ring. The primary trial outcomes are PrEP initiation (use of PrEP at 1\u00a0month), persistence (use of PrEP at 10\u00a0months), and adherence (quantified by levels of TFV or DPV in hair samples). Additionally, several secondary (STI incidence, PrEP method selection, predictors of PrEP adherence) and exploratory outcomes (HIV incidence, quality of care, contraceptive method mix) will be explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>We hypothesize pharmacy-delivered PrEP services supported with nurse navigator, versus delivered by pharmacy providers alone, will improve PrEP outcomes among AGYW seeking contraception. Our results will help policy makers better understand how to potentially implement this novel differentiated service model for PrEP and prime pharmacies for the delivery of new PrEP agents in the pipeline (e.g., long-acting injectables and multi-purpose technologies). The study was initiated on May 13, 2023, and is expected to be completed by February 2025.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov (NCT05467306), with registration on July 20, 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-024-08206-6","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T03:40:29Z","timestamp":1718768429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Harison K.","family":"Lagat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-7191","authenticated-orcid":false,"given":"Jillian","family":"Pintye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Houck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Kwena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Lenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Mogaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Momanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Mugambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Nyerere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Odoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Omollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina F.","family":"Ortblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greshon","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Bukusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"8206_CR1","unstructured":"Kenya Demographic and Health Survey 2014.pdf. Available from: \nhttps:\/\/dhsprogram.com\/pubs\/pdf\/fr308\/fr308.pdf.\u00a0[cited 2023 Jul 17]."},{"issue":"9","key":"8206_CR2","doi-asserted-by":"publisher","first-page":"e25619","DOI":"10.1002\/jia2.25619","volume":"23","author":"KF Ortblad","year":"2020","unstructured":"Ortblad KF, Mogere P, Bukusi E, Ngure K, Baeten JM. Pharmacy delivery to expand the reach of PrEP in Africa. J Int AIDS Soc. 2020;23(9):e25619.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"8206_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/QAI.0000000000001579","volume":"77","author":"KH Mayer","year":"2018","unstructured":"Mayer KH, Chan PA, Patel R, Flash CA, Krakower DS. Evolving models and ongoing challenges for HIV pre-exposure prophylaxis implementation in the United States. J Acquir Immune Defic Syndr 1999. 2018;77(2):119\u201327.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"1","key":"8206_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1331\/JAPhA.2015.14069","volume":"55","author":"KM Darin","year":"2015","unstructured":"Darin KM, Scarsi KK, Klepser DG, Klepser SA, Reeves A, Young M, et al. Consumer interest in community pharmacy HIV screening services. J Am Pharm Assoc JAPhA. 2015;55(1):67\u201372.","journal-title":"J Am Pharm Assoc JAPhA"},{"issue":"1","key":"8206_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","volume":"55","author":"KM Darin","year":"2015","unstructured":"Darin KM, Klepser ME, Klepser DE, Klepser SA, Reeves A, Young M, et al. Pharmacist-provided rapid HIV testing in two community pharmacies. J Am Pharm Assoc JAPhA. 2015;55(1):81\u20138.","journal-title":"J Am Pharm Assoc JAPhA"},{"key":"#cr-split#-8206_CR6.1","doi-asserted-by":"crossref","unstructured":"Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, et al. \"since both of us are using antiretrovirals, we have been supportive to each other\": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya: Facilitators. J Int AIDS Soc. 2016;19(1). Available from:","DOI":"10.7448\/IAS.19.1.21134"},{"key":"#cr-split#-8206_CR6.2","unstructured":"http:\/\/www.scopus.com\/inward\/record.url?scp=85001941006&partnerID=8YFLogxK.\u00a0[cited 2023 Jul 23]."},{"issue":"14","key":"8206_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1472-6963-14-231","volume":"21","author":"N Mack","year":"2014","unstructured":"Mack N, Odhiambo J, Wong CM, Agot K. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders. BMC Health Serv Res. 2014;21(14):231.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"8206_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/QAI.0000000000002876","volume":"89","author":"JE Haberer","year":"2022","unstructured":"Haberer JE, Mugo N, Bukusi EA, Ngure K, Kiptinness C, Oware K, et al. Understanding pre-exposure prophylaxis adherence in young women in Kenya. J Acquir Immune Defic Syndr 1999. 2022;89(3):251\u201360.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"1","key":"8206_CR9","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12913-020-05898-9","volume":"20","author":"KF Ortblad","year":"2020","unstructured":"Ortblad KF, Mogere P, Roche S, Kamolloh K, Odoyo J, Irungu E, et al. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation. BMC Health Serv Res. 2020;20(1):1034.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"8206_CR10","first-page":"689","volume":"24","author":"UA Igun","year":"1987","unstructured":"Igun UA. Why we seek treatment here: retail pharmacy and clinical practice in Maiduguri, Nigeria. Soc Sci Med 1982. 1987;24(8):689\u201395.","journal-title":"Soc Sci Med 1982"},{"issue":"1","key":"8206_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11096-005-4801-3","volume":"29","author":"N Viberg","year":"2007","unstructured":"Viberg N, Tomson G, Mujinja P, Lundborg CS. The role of the pharmacist-voices from nine African countries. Pharm World Sci PWS. 2007;29(1):25\u201333.","journal-title":"Pharm World Sci PWS"},{"issue":"12","key":"8206_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1472-6963-12-223","volume":"27","author":"FN Wafula","year":"2012","unstructured":"Wafula FN, Miriti EM, Goodman CA. Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature. BMC Health Serv Res. 2012;27(12):223.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"8206_CR13","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1007\/s10461-021-03229-5","volume":"25","author":"SD Roche","year":"2021","unstructured":"Roche SD, Wairimu N, Mogere P, Kamolloh K, Odoyo J, Kwena ZA, et al. Acceptability and feasibility of pharmacy-based delivery of pre-exposure prophylaxis in Kenya: a qualitative study of client and provider perspectives. AIDS Behav. 2021;25(12):3871\u201382.","journal-title":"AIDS Behav"},{"issue":"6","key":"8206_CR14","doi-asserted-by":"publisher","first-page":"e26131","DOI":"10.1002\/jia2.26131","volume":"26","author":"KF Ortblad","year":"2023","unstructured":"Ortblad KF, Mogere P, Omollo V, Kuo AP, Asewe M, Gakuo S, et al. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation. J Int AIDS Soc. 2023;26(6):e26131.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"8206_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/QAD.0000000000003447","volume":"37","author":"J Pintye","year":"2023","unstructured":"Pintye J, Odoyo J, Nyerere B, Achieng P, Araka E, Omondi C, et al. Nurse-facilitated preexposure prophylaxis delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya. AIDS. 2023;37(4):617.","journal-title":"AIDS"},{"key":"8206_CR16","unstructured":"\u201cPharmacies are Everywhere, and You can get it at any Time\u201d: experiences with pharmacy-based PrEP delivery among adolescent girls and young women in Kisumu, Kenya. Available from: \nhttps:\/\/reference.medscape.com\/medline\/abstract\/37997351.\u00a0[cited 2024 Jan 5]."},{"key":"8206_CR17","unstructured":"KENPHIA-2018_Preliminary-Report_final-web.pdf. Available from: \nhttps:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2020\/04\/KENPHIA-2018_Preliminary-Report_final-web.pdf.\u00a0[cited 2023 Aug 3]."},{"key":"8206_CR18","unstructured":"Kenya AIDS indicator survey 2012\u00a0: KAIS\u00a0: final report. Available from: \nhttps:\/\/stacks.cdc.gov\/view\/cdc\/26189.\u00a0[cited 2023 Aug 11]."},{"key":"8206_CR19","unstructured":"Kenya-ARV-Guidelines-2022-Final-1.pdf. Available from: \nhttps:\/\/www.differentiatedservicedelivery.org\/wp-content\/uploads\/Kenya-ARV-Guidelines-2022-Final-1.pdf.\u00a0[cited 2024 Jan 5]."},{"issue":"1","key":"8206_CR20","doi-asserted-by":"publisher","first-page":"e83736","DOI":"10.1371\/journal.pone.0083736","volume":"9","author":"AY Liu","year":"2014","unstructured":"Liu AY, Yang Q, Huang Y, Bacchetti P, Anderson PL, Jin C, et al. Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP). PLoS ONE. 2014;9(1):e83736.","journal-title":"PLoS ONE"},{"key":"8206_CR21","unstructured":"Adolescents-Guidance-on-HIV-SRH-Research.pdf. Available from: \nhttps:\/\/icop.or.ke\/wp-content\/uploads\/2016\/10\/Adolescents-Guidance-on-HIV-SRH-Research.pdf.\u00a0[cited 2023 Jul 29]."},{"issue":"22","key":"8206_CR22","doi-asserted-by":"publisher","first-page":"232595822312158","DOI":"10.1177\/23259582231215882","volume":"23","author":"M Vera","year":"2023","unstructured":"Vera M, Bukusi E, Achieng P, Aketch H, Araka E, Baeten J, et al. \u201cPharmacies are Everywhere, and You can get it at any Time\u201d: experiences with pharmacy-based PrEP delivery among adolescent girls and young women in Kisumu, Kenya. J Int Assoc Provid AIDS Care. 2023;23(22):23259582231215880.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"1","key":"8206_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/QAI.0000000000000386","volume":"68","author":"SM Baxi","year":"2015","unstructured":"Baxi SM, Liu A, Bacchetti P, Mutua G, Sanders EJ, Kibengo FM, et al. Comparing the novel method of assessing PrEP adherence\/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr 1999. 2015;68(1):13\u201320.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"9","key":"8206_CR24","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/infdis\/jiv239","volume":"212","author":"M Gandhi","year":"2015","unstructured":"Gandhi M, Glidden DV, Liu A, Anderson PL, Horng H, Defechereux P, et al. Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: implications for pre-exposure prophylaxis adherence monitoring. J Infect Dis. 2015;212(9):1402\u20136.","journal-title":"J Infect Dis"},{"issue":"12","key":"8206_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/sim.3582","volume":"28","author":"A Thomson","year":"2009","unstructured":"Thomson A, Hayes R, Cousens S. Measures of between-cluster variability in cluster randomized trials with binary outcomes. Stat Med. 2009;28(12):1739\u201351.","journal-title":"Stat Med"},{"issue":"2","key":"8206_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/096228020000900203","volume":"9","author":"RJ Hayes","year":"2000","unstructured":"Hayes RJ, Alexander ND, Bennett S, Cousens SN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res. 2000;9(2):95\u2013116.","journal-title":"Stat Methods Med Res"},{"issue":"10","key":"8206_CR27","doi-asserted-by":"publisher","first-page":"e0001978","DOI":"10.1371\/journal.pgph.0001978","volume":"3","author":"EK Harrington","year":"2023","unstructured":"Harrington EK, Congo O, Kimanthi S, Dollah A, Onono M, Mugo N, et al. Adaptation of the sexual and reproductive empowerment scale for adolescents and young adults in Kenya. PLOS Glob Public Health. 2023;3(10):e0001978.","journal-title":"PLOS Glob Public Health"},{"key":"8206_CR28","unstructured":"MEASURE Evaluation. Quick investigation of quality (QIQ): a user\u2019s guide for monitoring quality of care in family planning (2nd ed.). Chapel Hill: MEASURE Evaluation, University of North Carolina;\u00a0 2016. Available from: \nhttps:\/\/www.measureevaluation.org\/resources\/publications\/ms-15-104\/at_download\/document. [cited 2023 Jul 23]."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08206-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:07:48Z","timestamp":1718824068000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08206-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8206"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08206-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"10 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"University of Washington Institutional Review Board (STUDY00013956) and Kenya Medical Research Institute (KEMRI) Scientific Ethics Review Unit (Protocol No. KEMRI\/SERU\/CMR\/P00203-03\u20132022\/4507) approvals were obtained prior to study rollout. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, since we have neither images nor videos of an individual provided in the protocol. The participant information materials and informed consent form are available from the corresponding authors on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}